These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16809171)

  • 1. The prevention and care of HIV-infected drug users in contemporary Brazil.
    Bastos FI
    Subst Use Misuse; 2006; 41(6-7):833-4. PubMed ID: 16809171
    [No Abstract]   [Full Text] [Related]  

  • 2. Harm reduction: closing the distance.
    CMAJ; 2001 Aug; 165(4):389, 391. PubMed ID: 11531042
    [No Abstract]   [Full Text] [Related]  

  • 3. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
    Panda S; Sharma M
    Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
    Irwin K; Karchevsky E; Heimer R; Badrieva L
    Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.
    Rothman J; Rudnick D; Slifer M; Agins B; Heiner K; Birkhead G
    J Urban Health; 2007 Mar; 84(2):226-42. PubMed ID: 17216572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Ukraine is tackling Europe's worst HIV epidemic.
    Hurley R
    BMJ; 2010 Jul; 341():c3538. PubMed ID: 20627980
    [No Abstract]   [Full Text] [Related]  

  • 8. Prisoners who inject drugs: public health and human rights imperatives.
    Jürgens R; Betteridge G
    Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus seroprevalence: selected health care settings in Texas.
    Melville SK; Heseltine G; Delamater E; Gilani Z; Hendricks K; Suarez L
    Tex Med; 2006 Mar; 102(3):56-61. PubMed ID: 17115588
    [No Abstract]   [Full Text] [Related]  

  • 10. Threat or opportunity? Secondary exchange in a setting with widespread availability of needles.
    Lenton S; Bevan J; Lamond T
    Subst Use Misuse; 2006; 41(6-7):845-64. PubMed ID: 16809175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle exchange and the HIV outbreak among injection drug users in Vancouver, Canada.
    Wood E; Kerr T
    Subst Use Misuse; 2006; 41(6-7):841-3. PubMed ID: 16809174
    [No Abstract]   [Full Text] [Related]  

  • 12. The invisible IDU.
    Raymond D
    GMHC Treat Issues; 2005; 19(5-6):16. PubMed ID: 16193580
    [No Abstract]   [Full Text] [Related]  

  • 13. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R; Karimi A; Rouzbahani R; Rouzbahani A
    East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incarceration and infection: drug policy in the USA.
    Burki T
    Lancet Infect Dis; 2017 Jul; 17(7):697. PubMed ID: 28737490
    [No Abstract]   [Full Text] [Related]  

  • 15. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT).
    Booth RE; Strathdee SA
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S1-3. PubMed ID: 17889451
    [No Abstract]   [Full Text] [Related]  

  • 16. Motives for and against injecting drug use among young adults in Amsterdam: qualitative findings and considerations for disease prevention.
    Witteveen E; Van Ameijden EJ; Schippers GM
    Subst Use Misuse; 2006; 41(6-7):1001-16. PubMed ID: 16809183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstacles to the development of prevention and public health policies in Argentina.
    Touzé G
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system.
    Mojtahedzadeh V; Razani N; Malekinejad M; Vazirian M; Shoaee S; Saberi Zafarghandi MB; Hernandez AL; Mandel JS
    AIDS Behav; 2008 Jul; 12(4 Suppl):S7-12. PubMed ID: 18521737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The organization of a community: community-based prevention of injecting drug use-related health problems.
    Carruthers S
    Subst Use Misuse; 2007; 42(12-13):1971-7. PubMed ID: 18075921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.